title: Hurry up and wait: is accelerated approval of new cancer drugs in the best interests of cancer patients?
authors.forename: Richard L
authors.initials: RL
authors.lastname: Schilsky
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017277:Drug Approval / Q000379:methods*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents